This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Angela Lopez-Gitlitz: Innovator in Prostate Cancer Treatment
Introduction
Angela Lopez-Gitlitz is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of cancer treatment, particularly focusing on prostate cancer. Her innovative approach combines various therapeutic agents to enhance treatment efficacy.
Latest Patents
Angela holds a patent for the treatment of prostate cancer using a combination of abiraterone acetate, niraparib tosylate monohydrate, and prednisone. This patent outlines methods for utilizing both free-dose and fixed-dose combinations of these agents to improve patient outcomes in prostate cancer therapy.
Career Highlights
Angela is currently associated with Janssen Pharmaceutica NV, where she continues to advance her research and development efforts. Her work has been instrumental in exploring new avenues for cancer treatment, showcasing her dedication to improving patient care.
Collaborations
Angela has collaborated with notable colleagues, including Johny Bertels and Paul J A Hartman Kok. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in cancer treatment.
Conclusion
Angela Lopez-Gitlitz exemplifies the spirit of innovation in the medical field, particularly in the treatment of prostate cancer. Her contributions through her patent and collaborative efforts highlight her commitment to advancing healthcare solutions.